Veracyte, Inc. (NASDAQ:VCYT) saw a 7.04% increase in share price after being added to the S&P SmallCap 600 index on July 29. The stock closed at $25.25 on Friday, following the removal of Triumph Group due to a merger. Companies often experience a boost in visibility and investment when added to major market indices.

Veracyte, Inc. (NASDAQ:VCYT) will announce second-quarter financial results on August 6, after market close. A conference call at 4:30 PM will provide further details on the company’s performance. Veracyte is a global diagnostics company focused on advancing cancer care. Some investors see potential in VCYT, but others believe other AI stocks offer better returns with less risk. For more information on a promising AI stock, check out our free report.

Read more at Yahoo Finance: Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion